Letybo 50 units

Letybo 50 units is a medicine authorised by Swissmedic under authorisation number 68864. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 October 2023 and the authorisation is limited until 11 October 2028. ATC code M03AX01 places the medicine in the group Muscle relaxants.

  • Dispensing category A
  • Authorisation number 68864
  • ATC M03AX01
  • Biotechnological medicines
Authorisation data
Authorisation number68864
NameLetybo 50 units
Full nameLetybo 50 units , Pulver zur Herstellung einer Injektionslösung
Authorisation holderMedius AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeM03AX01
First authorisation12 October 2023
Authorisation validity11 October 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Letybo 50 units , Pulver zur Herstellung einer InjektionslösungA12 October 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)M03AX0101.13.0.A
22Durchstechflasche(n)M03AX0101.13.0.A
36Durchstechflasche(n)M03AX0101.13.0.A
42Durchstechflasche(n)M03AX0101.13.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Letybo 50 units authorised in Switzerland?

Yes. Letybo 50 units is authorised by Swissmedic under authorisation number 68864, data as of 01 September 2026. The authorisation is limited until 11 October 2028.

Which dispensing category does Letybo 50 units have?

Letybo 50 units is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Letybo 50 units?

The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com